DEUTSCHE BANK AG\ - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 84 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$60,000
-54.5%
52,999
-9.6%
0.00%
Q4 2021$132,000
-88.8%
58,637
-83.0%
0.00%
-100.0%
Q3 2021$1,178,000
+15.6%
344,423
+1.0%
0.00%
Q2 2021$1,019,000
-12.1%
341,127
-4.9%
0.00%
-100.0%
Q1 2021$1,159,000358,854
+289298.4%
0.00%
Q1 2018$0124
-44.4%
0.00%
Q4 2017$0
-100.0%
223
-100.0%
0.00%
-100.0%
Q3 2017$990,000
+188.6%
745,668
+240.2%
0.00%
Q2 2017$343,000
-55.4%
219,196
-8.2%
0.00%
-100.0%
Q1 2017$769,000
+17.9%
238,758
-50.7%
0.00%0.0%
Q4 2016$652,000
-28.0%
483,875
-16.8%
0.00%0.0%
Q3 2016$905,000
+120.7%
581,435
+86.7%
0.00%
Q2 2016$410,000
-79.4%
311,353
-17.8%
0.00%
-100.0%
Q1 2016$1,994,000
-44.5%
378,769
-17.4%
0.00%0.0%
Q4 2015$3,596,000
+7.9%
458,526
+16.2%
0.00%
-33.3%
Q3 2015$3,333,000
-30.5%
394,738
-9.9%
0.00%0.0%
Q2 2015$4,796,000
-37.9%
438,221
-20.6%
0.00%
-40.0%
Q1 2015$7,718,000
+8.4%
552,201
+30.9%
0.01%
+25.0%
Q4 2014$7,121,000
+28.3%
421,767
+1.9%
0.00%
+33.3%
Q3 2014$5,552,000
+12.8%
413,958
+7.1%
0.00%0.0%
Q2 2014$4,920,000
-32.3%
386,390
-36.9%
0.00%
-40.0%
Q1 2014$7,265,000
-22.6%
612,092
-10.1%
0.01%
-28.6%
Q4 2013$9,386,000
+133.1%
681,160
+194.7%
0.01%
+133.3%
Q3 2013$4,026,000231,1130.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders